Tuberculosis is a communicable disease that is a major cause of ill health, and one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent (ranking above HIV/AIDS). CBNAAT marks an important development in the field of rapid molecular tuberculosis diagnosis. Diabetes triples the risk of developing tuberculosis, and poor glycemic control adversely affects tuberculosis treatment outcomes with effects such as prolongation of culture conversion, treatment failure, relapse, and death